GetPortalImpactFactorByIdResp(projectId=1, id=bd706061, cover=https://img.medsci.cn/images/journal/cover/2021/NSS_202109271316193360.jpg, fullname=PHARMACOLOGICAL RESEARCH, abbr=PHARMACOL RES, pyear=1989, frequence=Monthly, articleNumbers=3070, citedSelf2015=3.8, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.87月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1043-6618, greenSci=https://www.greensci.net/search?kw=1043-6618, scijournal=https://www.scijournal.org/impact-factor-of-PHARMACOL-RES.shtml, medsciHotlightString=null, medsciHotlightRealtime=35.567, medsciHotlight=31.434, medsciHotlight5year=25.107, citescore=10.1, hIndex=132, impactFactor=9.3, orgnization=Academic Press Inc., orgnizationUrl=http://www.elsevier.com, country=United States, countryCn=美国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 2区[Top], smallclassCas=医学 2 区, website=https://www.elsevier.com/wps/find/journaldescription.cws_home/622931/description#description, websiteHits=28829, guideForAuthor=https://www.elsevier.com/journals/pharmacological-research/1043-6618/guide-for-authors, guideForAuthorHits=983, submitWebsite=https://www.editorialmanager.com/yphrs/|https://www.editorialmanager.com/yphrs/, submitWebsiteHits=11061, content=<p><em style="color: #2e2e2e;">Pharmacological Research</em><span style="color: #2e2e2e;"> publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. We provide a venue through which specialists across disciplines can rapidly exchange information in health sciences that pertains to modern pharmacological topics. The journal publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials); it is proud of its rapid publication of accepted papers that comprises a dedicated, fast acceptance and publication track for high profile articles.</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><span style="color: #2e2e2e;">Invited and unsolicited review articles are welcome.</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><u style="color: #2e2e2e;"><strong>Journal Sections</strong></u><br style="color: #2e2e2e;" /><span style="color: #2e2e2e;">Specific sections are dedicated to:</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><strong style="color: #2e2e2e;">The cardiovascular system:</strong></p> <ul style="color: #2e2e2e;"> <li>CV disease therapy;</li> <li>Signal transduction and receptor pharmacology in the CV system;</li> <li>Target organs;</li> <li>Clinical trials.</li> </ul> <p><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><strong style="color: #2e2e2e;">Neuroscience, including psychopharmacology, and neuroendocrinology:</strong></p> <ul style="color: #2e2e2e;"> <li>Understanding of the central nervous system in physiological and pathological conditions;</li> <li>Neuropharmacological and molecular mechanisms of learning and memory;</li> <li>Therapeutic and diagnostic challenges for mental illness and neurodegerative diseases;</li> <li>System biology.</li> </ul> <p><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><strong style="color: #2e2e2e;">Oncology:</strong></p> <ul style="color: #2e2e2e;"> <li>Targeted cancer therapy;</li> <li>Precision medicine and personalized therapy;</li> <li>Signal transduction studies, as related to drug action;</li> <li>Clinical trials.</li> </ul> <p><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><strong style="color: #2e2e2e;">Immunology (clinical and basic):</strong></p> <ul style="color: #2e2e2e;"> <li>Immune and inflammatory mechanisms including target identification;</li> <li>Immunotherapy and immunotoxicology;</li> <li>Immunopathology;</li> <li>Vaccines and adjuvants;</li> <li>Treatment of infectious diseases.</li> </ul> <p><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><strong style="color: #2e2e2e;">Redox regulators and biological gases in pathophysiology:</strong></p> <ul style="color: #2e2e2e;"> <li>Oxidative and nitrative stress and cell dysfunction;</li> <li>Redox regulation of signal transduction in various diseases;</li> <li>Pathophysiological roles of NO, CO and H2S;</li> <li>Interaction between oxidants and gaseous mediators in health and disease;</li> <li>Pharmacological modulators of oxidants, free radicals and gaseous transmitters.</li> </ul> <p><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><strong style="color: #2e2e2e;">Renal Pathophysiology and Pharmacology:</strong></p> <ul style="color: #2e2e2e;"> <li>Acute and chronic kidney injury disease;</li> <li>Metabolic alkalosis and metabolic acidosis in renal disease;</li> <li>Renal excretion in electrolyte disorders;</li> <li>Diabetes insipidus, Diabetic nephropathy;</li> <li>Pathogenesis of glomerular disease;</li> <li>End stage renal disease;</li> <li>Prevention and treatment of nephrotic diseases.</li> </ul> <p><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><strong style="color: #2e2e2e;">Pregnancy Related Pharmacology and Perinatal Therapeutics:</strong></p> <ul style="color: #2e2e2e;"> <li>Drug effects on the mother and foetus before and after birth;</li> <li>Placental barrier and its relationship with drugs (transportation metabolism and so on);</li> <li>Molecular signalling in placenta and identification of mechanisms beyond drug action in pregnancy;</li> <li>Adverse effects of drugs drug/combination in placenta;</li> <li>Drug repurposing/reprogramming for placenta-related disorders;</li> <li>Regulatory aspects beyond clinical research in pregnant mothers;</li> <li>Placenta remodelling in disease;</li> <li>In vivo models of the diseased placenta;</li> <li>The microbioma;</li> <li>Effects of the environment on pregnancy;</li> <li>Preventive vs therapeutic use of drugs.</li> </ul> <p><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><strong style="color: #2e2e2e;">Pharmacogenomics, Pharmacogenetics and Precision Medicine:</strong></p> <ul style="color: #2e2e2e;"> <li>We are especially interested in GWAS studies and studies reporting pharmacogenetic data that are relevant in terms of safety and efficacy of drugs. They must provide insight into novel genomic or therapeutic associations that can help guide therapy selection or suggest new indications for established drugs. Studies can also provide details of exceptional responses in limited numbers of patients.</li> <li>We also publish n=1 studies of exceptional responses, provided they are backed up by compelling genomic or experimental data.</li> <li>Studies must include full clinical description of the case, along with details of the response and supporting molecular information. The molecular information should support the clinical observations and offer a definitive pharmacogenomic insight. Standard clinical sequencing assays (Foundation ONE, Genoptix etc) are only appropriate when the therapeutic or phenotypic response is novel. Ideally, the observational patient studies should be supported by lab based functional data.</li> </ul> <p><strong style="color: #2e2e2e;">Bioactive molecules derived from medicinal plants or natural products:</strong></p> <ul style="color: #2e2e2e;"> <li>New, effective bioactive molecules;</li> <li>Drug target identification;</li> <li>Treatment mechanism;</li> <li>Mechanism investigation with -omics and computational technologies;</li> <li>Combinational therapy with natural products;</li> <li>Multi-targeting and network pharmacology;</li> <li>Herbal bioinformatics;</li> <li>Precision medicine of natural products;</li> <li>Evidenced-based research and clinical trials.</li> </ul> <p><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><span style="color: #2e2e2e;">Studies reporting on plant extracts in which the active principle(s) has not been defined do not fall into the scope of this journal. Exceptions can be made for papers addressing the mechanisms of actions or the clinical applications of standardized herbal preparations. Clinical studies on commercially-available nutraceuticals are also taken into consideration.</span><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><strong style="color: #2e2e2e;">Rare diseases and orphan drugs, and drug repositioning</strong><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><span style="color: #2e2e2e;">We also publish articles focusing on:</span></p> <ul style="color: #2e2e2e;"> <li><strong>Gastrointestinal and urogenital apparatuses when involving pharmacological issues</strong>;</li> <li><strong>Pharmacology of tissue repair/regeneration</strong>;</li> <li><strong>Pharmacology of aging</strong>;</li> <li><strong>Nutraceuticals (if relevant to human disease)</strong>;</li> <li><strong>Pharmacoeconomy</strong>;</li> <li><strong>Pharmacoepidemiology</strong>.</li> </ul> <p><br style="color: #2e2e2e;" /><br style="color: #2e2e2e;" /><span style="color: #2e2e2e;">We do </span><u style="color: #2e2e2e;">not</u><span style="color: #2e2e2e;"> publish:</span></p> <ul style="color: #2e2e2e;"> <li>Papers reporting pharmacological activities of novel compounds if no proper controls with known substances are performed;</li> <li>Bioequivalence studies or studies reporting only the pharmacokinetics profile of a compound;</li> <li>Descriptive pharmacovigilance studies;</li> <li>Single dose/concentration studies and those measuring only one endpoint.</li> </ul>, totalCites=28557, brief=PHARMACOL RES杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的中等级别杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #ff0000;"><span style="color: #ff00ff;">洋红</span></span>, medsciComment=PHARMACOL RES属于国际顶级杂志，居于一线期刊，但是国内关注人数不算太多，投稿也许有些机会。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=bd706061'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=4407, tagName=机制, createdHits=10), ImpactFactorTagDto(id=9721, tagName=药效, createdHits=8), ImpactFactorTagDto(id=10874, tagName=药理, createdHits=7), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=6), ImpactFactorTagDto(id=4724, tagName=疗效, createdHits=5), ImpactFactorTagDto(id=3184, tagName=综述, createdHits=5), ImpactFactorTagDto(id=721, tagName=靶向治疗, createdHits=4), ImpactFactorTagDto(id=1113, tagName=药物治疗, createdHits=4), ImpactFactorTagDto(id=3270, tagName=动物模型, createdHits=4), ImpactFactorTagDto(id=11, tagName=中药, createdHits=3), ImpactFactorTagDto(id=5121, tagName=人体, createdHits=2), ImpactFactorTagDto(id=5521, tagName=分子机制, createdHits=2), ImpactFactorTagDto(id=1660, tagName=炎症, createdHits=2), ImpactFactorTagDto(id=43705, tagName=单体, createdHits=2), ImpactFactorTagDto(id=456965, tagName=拒稿后修改重新投稿, createdHits=2), ImpactFactorTagDto(id=41490, tagName=中药单体, createdHits=1), ImpactFactorTagDto(id=12920, tagName=重症感染, createdHits=1), ImpactFactorTagDto(id=205, tagName=免疫, createdHits=1), ImpactFactorTagDto(id=475394, tagName=肿瘤治疗抵抗, createdHits=1), ImpactFactorTagDto(id=6755, tagName=主动脉夹层, createdHits=1), ImpactFactorTagDto(id=111835, tagName= 分子机制 , createdHits=1), ImpactFactorTagDto(id=111585, tagName= 药理 , createdHits=1), ImpactFactorTagDto(id=111612, tagName= 机制 , createdHits=1), ImpactFactorTagDto(id=429, tagName=肝癌, createdHits=1), ImpactFactorTagDto(id=41736, tagName=cardiovascular, createdHits=1), ImpactFactorTagDto(id=357, tagName=肝细胞癌, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=5.12), GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.82), GetImpactFactorCiteScoreListResponse(year=2018, citescore=5.27), GetImpactFactorCiteScoreListResponse(year=2019, citescore=9.9), GetImpactFactorCiteScoreListResponse(year=2020, citescore=10.1)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=31.635), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=35.902), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=42.714), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=36.929), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=35.567)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=16/300)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1043-6618[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=PHARMACOLOGICAL RESEARCH[ta], article_number=478, article_number_cn=238, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)